Home ⟩ Insights

Insights

analyst-ratings

1 min read • December 6, 2021

Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Lowers Price Target to $72

2 min read • November 11, 2021

As Green Thumb’s Shares Go Up Post Earnings, Analyst Says Stock Will Benefit From Cannabis Legalization

1 min read • November 10, 2021

Cantor Fitzgerald Maintains Neutral on Aurora Cannabis, Raises Price Target to C$10.75

2 min read • October 29, 2021

Will Hexo’s New CEO Help The Cannabis Giant Pivot Towards Positive EBITDA?

3 min read • October 29, 2021

U.S. Cannabis Industry is ‘Flourishing’ In Spite Of (Or Because Of?) General Economic Downturn

4 min read • October 15, 2021

Piper Sandler’s Michael Lavery Shares Cannabis Industry Projections, Names ‘The Real Key Catalyst To Watch’

2 min read • October 13, 2021

Viridian Capital Advisors’ Pres Scott Greiper To Be Featured At Benzinga’s Cannabis Capital Conference

3 min read • October 11, 2021

Analyst Explains Why Jushi Is One Of The Best Cannabis Stocks Among Leading MSOs

24 min read • October 6, 2021

Outperforming Cannabis Stocks Without Federal Legislation: These Top MSO Picks Will Surprise You

2 min read • October 5, 2021

Analysis: Aurora Cannabis Could Improve Position Based On Exports, Jushi Price Target Adjusted Down

1 min read • October 5, 2021

Cantor Fitzgerald Maintains Neutral on Aurora Cannabis, Raises Price Target to C$9.5

1 min read • October 5, 2021

Roth Capital Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of $8

Latest Headlines

5 min read • September 2, 2026

Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights

10 min read • September 2, 2026

Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround

3 min read • September 2, 2026

Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows

2 min read • September 2, 2026

UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share

7 min read • September 2, 2026

Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation

3 min read • September 1, 2026

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

8 min read • September 1, 2026

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

2 min read • September 1, 2026

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.